Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

lecanemab

lecanemab
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Leqembi INJECTION, INTRAVENOUS 100 mg/mL      
Leqembi Iqlik Autoinjector INJECTION, SUBCUTANEOUS 360 mg/1.8 mL      
VIEW MORE Monoclonal Antibodies, Alzheimer Disease Agents
Comments:

Restricted to neurologist use of the intravenous route of administration in the hospital outpatient setting for up to 18 months. The subcutaneous auto-injector is non-formulary. Inpatients may use their home supply of subcutaneous auto-injector if needed.

 

Reviewed: July 2026

Lecanemab IV and SubQ Final without study updatedocx.pdf

Last updated: Aug. 14, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved